{"nct_id":"NCT03609619","title":"PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2018-08-17","start_date_type":"ACTUAL","primary_completion_date":"2018-11-23","primary_completion_date_type":"ACTUAL","completion_date":"2018-11-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AVTX"]}